1. CDK1-mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance
- Author
-
Shuaib Juma, Lili Qin, Xiaodi Zhang, Rui Liu, Ming Fan, Cuihong Jin, Andrew T M Vaughan, Julian R Perks, Jian Jian Li, Chun Xu Hai, June X. Zou, Tieqiao Zhang, Robert F. Li, Lun Quan Sun, David Gius, Demet Candas, and Angela Eldridge
- Subjects
Transcriptional Activation ,Cancer Research ,Aging ,SIRT3 ,Transcription, Genetic ,Oncology and Carcinogenesis ,Mitochondrion ,Radiation Tolerance ,Article ,Cell Line ,Mitochondrial Proteins ,Genetic ,Radioresistance ,Cell Line, Tumor ,Neoplasms ,Sirtuin 3 ,Breast Cancer ,CDC2 Protein Kinase ,Genetics ,Animals ,Humans ,Oncology & Carcinogenesis ,Phosphorylation ,Transcription factor ,Cancer ,Cyclin-dependent kinase 1 ,Neoplastic ,Tumor ,biology ,Animal ,Prevention ,NF-kappa B ,Acetylation ,Pharmacology and Pharmaceutical Sciences ,Cyclin-Dependent Kinases ,Mitochondria ,Enzyme Activation ,Gene Expression Regulation, Neoplastic ,Disease Models, Animal ,Oncology ,Gene Expression Regulation ,Sirtuin ,Disease Models ,Mutation ,biology.protein ,Cancer research ,Cell aging ,Transcription - Abstract
Tumor adaptive resistance to therapeutic radiation remains a barrier for further improvement of local cancer control. SIRT3, a member of the sirtuin family of NAD+-dependent protein deacetylases in mitochondria, promotes metabolic homeostasis through regulation of mitochondrial protein deacetylation and plays a key role in prevention of cell aging. Here, we demonstrate that SIRT3 expression is induced in an array of radiation-treated human tumor cells and their corresponding xenograft tumors, including colon cancer HCT-116, glioblastoma U87, and breast cancer MDA-MB231 cells. SIRT3 transcriptional activation is due to SIRT3 promoter activation controlled by the stress transcription factor NF-κB. Posttranscriptionally, SIRT3 enzymatic activity is further enhanced via Thr150/Ser159 phosphorylation by cyclin B1–CDK1, which is also induced by radiation and relocated to mitochondria together with SIRT3. Cells expressing Thr150Ala/Ser159Ala-mutant SIRT3 show a reduction in mitochondrial protein lysine deacetylation, Δψm, MnSOD activity, and mitochondrial ATP generation. The clonogenicity of Thr150Ala/Ser159Ala-mutant transfectants is lower and significantly decreased under radiation. Tumors harboring Thr150Ala/Ser159Ala-mutant SIRT3 show inhibited growth and increased sensitivity to in vivo local irradiation. These results demonstrate that enhanced SIRT3 transcription and posttranslational modifications in mitochondria contribute to adaptive radioresistance in tumor cells. CDK1-mediated SIRT3 phosphorylation is a potential effective target to sensitize tumor cells to radiotherapy. Mol Cancer Ther; 14(9); 2090–102. ©2015 AACR.
- Published
- 2015